Monthly Archives: December 2013

NYC Launches $100M Life Science Fund

On Tuesday, Deputy Mayor Robert Steel announced that the city is launching the New York City Emerging Life Science Technology Investment Fund, a $100 million venture fund for life sciences research. New York City will invest $10 million along with $40 million from Eli Lilly, Celgene and GE Ventures, with the remaining $50 million matched by venture capital partnerships. The fund will be used to invest in 15-20 early-stage research and development companies by 2020. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Canada Surpasses the US in the Approval of AquaBounty GM Salmon Eggs

1278946009098-e1386174723242 copy

In its recent article titled, AquaBounty GM Salmon Eggs Cleared for Production in Canada, The Fish Site, highlights a much needed success story in the field of animal biotechnology, “Environment Canada, the agency of the Government of Canada with responsibility for regulating environmental policies and issues, has decided that Genetically Modified (GM) AquAdvantage® Salmon from AquaBounty Technologies is not harmful to the environment or human health when produced in contained facilities. “AquaBounty will therefore now Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

87881842

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), will spur capital formation by increasing liquidity for emerging growth companies, including biotech innovators, that trade on the public market. Why you should care: Under current U.S. Securities and Exchange Commission (SEC) rules, all securities on the public market are priced in $0.01 increments. This minimum trading increment is known as the “tick size.” The switch to the standard tick Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Innovation Act Threatens Biotech Innovation

AB23475

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. The Innovation Act was introduced with the goal of furthering patent system reform, particularly with respect to patent-related litigation. We support increased transparency and oppose abusive litigation tactics. However, provisions in the Act remain overly broad in important respects and, if ultimately enacted, would continue to result in too many unintended and unknowable consequences for innovators who rely on the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Children in Philippines Receive Vaccines Against Measles, Polio

Vaccination

The Government of the Philippines with support from UNICEF, the World Health Organization (WHO), and other partners recently announced a mass campaign to vaccinate more than 30,000 children against measles and polio in typhoon-hit Tacloban. They also received Vitamin A supplements to help improve their immunity against infections. More than 5,000 people were killed and more than 1,600 people are missing two weeks after Typhoon Haiyan swept through the Philippines. More than a million homes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,